RNA, Ro-associated Y4 pseudogene 19 (RNY4P19)

RNY4 pseudogene 19 (RNY4P19) is a genomic pseudogene annotated as a non-coding RNA locus highly homologous to the functional Y RNA RNY4. Pseudogenes like RNY4P19 typically arise by duplication or retrotransposition of a parent gene (in this case, RNY4), but do not encode functional RNA or protein products. There is no evidence that RNY4P19 is transcribed or has a documented biological function or clinical role. Research has primarily focused on functional Y RNAs (such as RNY4), which participate in RNA quality control, DNA replication initiation, and may act as exosome-contained non-coding RNAs with potential cancer biomarker relevance[1][4]. Some Y RNA pseudogenes, including those very similar to RNY4P19, contribute non-specifically to RNA-seq alignments due to high sequence similarity, but this does not reflect an independent function. As of current knowledge, RNY4P19 itself is not a recognized therapeutic target and is mostly relevant as a reference point in genomic or transcriptomic analysis. Key clarification: - RNY4P19 is a *pseudogene* and is not the same as the *functional RNY4 gene*, which is under active investigation for its role as an exosomal RNA biomarker and potential participant in tumor microenvironment modulation[1][4]. - Pseudogenes (including RNY4P19) sometimes participate in post-transcriptional regulation as miRNA decoys or via antisense transcripts, but no such role is yet known or described for RNY4P19[2]. - In transcriptome or exosome studies, reads may non-specifically align to RNY4P19 or related pseudogenes due to sequence homology, but this does not imply targetability or functional disease association[1][4]. Conclusion: - RNY4P19 is a pseudogene, not a therapeutic target, and should be distinguished from the functional roles attributed to RNY4 or its processed RNA fragments[1][4][2].

Other names

RNY4P19RNA, Ro-associated Y4 pseudogene 19